Granulomatosis with Polyangiitis - 4 Studies Found
| Completed |
: PR3-AAV Resilient Remission or PRRR : Granulomatosis With Polyangiitis : 2025-08-01 : 1000 mg per infusion given approximately two weeks apart, on day 1 and on day 15 |
| COMPLETED |
: Maintenance of Remission with Rituximab Versus Azathioprine for Newly-diagnosed or Relapsing Eosinophilic Granulomatosis with Polyangiitis. : Eosinophilic Granulomatosis with Polyangiitis : 2025-08-01 : pre-emptive 500-mg fixed-dose of IV rituximab every 6 months (total duration of 18 months = 4 infusions) |
| COMPLETED |
: The Assessment of Prednisone In Remission Trial - Centers of Excellence Approach : Granulomatosis With Polyangiitis : 2025-08-01 : Subjects will remain on daily prednisone dose of 5 mg |
| COMPLETED |
: FASENRA Regulatory Postmarketing Surveillance in Korea : Asthma, EGPA(Eosinophilic Granulomatosis With Polyangiitis) : 2025-08-01 |